Some cancer lineages (e.g., brain, liver, skin, and bladder) frequently acquire recurrent mutations in the TERT promoter (TERTp) region, predominantly at −124 and −146 loci upstream from TERT transcription start site12–15. This evidence concerns the gene TERT and cancer.